Cholesterol Lowering Via Bempedoic Acid/Ezetimibe, an ACL-Inhibiting Regimen in Acute Coronary Syndrome Study
Clinical trial NCT05263778 · UNKNOWN
Trial details
- NCT number
- NCT05263778
- Sponsor
- Kaiser Permanente
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-01
- Primary completion
- 2023-06-01
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.